Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1976 May 8;1(6018):1116–1118. doi: 10.1136/bmj.1.6018.1116

A controlled comparison of flupenthixol and amitriptyline in depressed outpatients.

J P Young, W C Hughes, M H Lader
PMCID: PMC1639983  PMID: 773506

Abstract

Sixty depressed outpatients were allocated to treatment with either amitriptyline (75-225 mg/day) or flupenthixol (1-5-4-5 mg/day) in flexible dosage for six weeks under double-blind procedures. Various objective and subjective assessments were carried out before and after one, three, and six weeks of treatment. Twenty-three patients completed the course of amitriptyline and 28 the course of flupenthixol. Almost all variables improved significantly over time, irrespective of drug. On most ratings there were no significant differences between the two drugs, but the trends favoured flupenthixol. In particular, flupenthixol lessened anxiety scores more than amitriptyline. Unwanted effects were few and not troublesome except in two patients receiving amitriptyline. Flupenthixol, in low dosage, is a useful alternative antidepressant for depressed outpatients.

Full text

PDF
1116

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abenson M. H. Chlorimipramine in the treatment of severe depression. Br J Psychiatry. 1971 Aug;119(549):230–231. doi: 10.1192/bjp.119.549.230-a. [DOI] [PubMed] [Google Scholar]
  2. Frolund F. Treatment of depression in general parctice: a controlled trial of flupenthixol ('Fluanxol'). Curr Med Res Opin. 1974;2(2):78–89. doi: 10.1185/03007997409114249. [DOI] [PubMed] [Google Scholar]
  3. Hare E. H., Willcox D. R. Do psychiatric in-patients take their pills? Br J Psychiatry. 1967 Dec;113(505):1435–1439. doi: 10.1192/bjp.113.505.1435. [DOI] [PubMed] [Google Scholar]
  4. Nisticó G., Marano V., Scapagnini U. Flupentixol in depression. Acta Neurol (Napoli) 1975 Jan-Feb;30(1):102–108. [PubMed] [Google Scholar]
  5. OVERALL J. E., HOLLISTER L. E., MEYER F., KIMBELL I., Jr, SHELTON J. IMIPRAMINE AND THIORIDAZINE IN DEPRESSED AND SCHIZOPHRENIC PATIENTS. ARE THERE SPECIFIC ANTIDEPRESSANT DRUGS? JAMA. 1964 Aug 24;189:605–608. doi: 10.1001/jama.1964.03070080011002. [DOI] [PubMed] [Google Scholar]
  6. Predescu V., Ciurezu T., Timofte G., Roman I. Symptomatic relief with flupentixol (Fluanxol) of the anxious-algetic-depressive syndrome complex in neurotic states. A double-blind, placebo-controlled study. Acta Psychiatr Scand. 1973;49(1):15–27. doi: 10.1111/j.1600-0447.1973.tb04396.x. [DOI] [PubMed] [Google Scholar]
  7. Reiter P. J. On flupentixol, an antidepressant of a new chemical group. Br J Psychiatry. 1969 Dec;115(529):1399–1402. doi: 10.1192/bjp.115.529.1399. [DOI] [PubMed] [Google Scholar]
  8. Rosenberg I. U., Ostensen A. I., Fonnelo H. Dobbeltblind klinisk multisenterundersøkelse i almenpraksis av flupentixol mot nortriptylin hos pasienter med angst-depresjon-asteni ("ADA-syndromet") Tidsskr Nor Laegeforen. 1976 Feb 10;96(4):229-33, 255. [PubMed] [Google Scholar]
  9. Sonne L. M. Behandling af depressive tilstande med flupenthixol. Nord Psykiatr Tidsskr. 1971;25(5):454–462. doi: 10.3109/08039487109094695. [DOI] [PubMed] [Google Scholar]
  10. Sonne L. M. Behandling af depressive tilstande med flupentixol. Nord Psykiatr Tidsskr. 1966;20(4):322–324. doi: 10.3109/08039486609097604. [DOI] [PubMed] [Google Scholar]
  11. Tyrer P., Candy J., Kelly D. Phenelzine in phobic anxiety: a controlled trial. Psychol Med. 1973 Feb;3(1):120–124. doi: 10.1017/s0033291700046419. [DOI] [PubMed] [Google Scholar]
  12. Van Coller P. E. Flupenthixol (fluanxol) in the treatment of psychosomatic disorders in medicine. Psychosomatics. 1971 Jul-Aug;12(4):256–259. doi: 10.1016/S0033-3182(71)71516-3. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES